
|Articles|September 14, 2021
Egnyte Announces Solution for Trial Operations
Advertisement
Egnyte has announced Egnyte for Life Sciences eTMF, a product for the clinical development functions at life science companies to manage trial master file data. Egnyte for Life Sciences eTMF is 21 CFR Part 11 compliant solution that aims to reduce document processing time while maintaining compliance and audit readiness.
Egnyte for Life Sciences eTMF solution enables clinical development professionals to:
- Stay on track with milestones: built on Egnyte’s secure collaboration platform, get full visibility into study milestones, allowing clinical teams to communicate with sites to stick to timelines.
- Maintain control of trial information: Egnyte’s governance features allow teams to flag missing source documents, leverage AI and ML features for constant monitoring for misclassified documents or embedded PII/PHI.
- Be audit-ready and compliant: meeting GxP and FDA 21 CFR Part 11 requirements, Egnyte allows companies to stay audit-ready and maintain compliance in a cloud-based solution.
More about
Advertisement
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
Beyond Compliance: ProofPilot's Joseph Kim and Lauren Briggs on Making Clinical Trial Training Actually Work
2
Tufts CSDD Analysis Finds AI Clinical Monitoring Agent Can Generate Up to $21 Million in Net Financial Value Per Drug Development Program
3
ACT Brief: Efficacy Ceiling Breakthrough in Autoimmune Disease, Early-Career Retention and Burnout Prevention, and PRV Program Catalyzing Rare Disease Investment
4
Breaking the Efficacy Ceiling in IBD and Beyond
5



